» Download Public Reports
About 200 reports
- Company report
- December 2012
- 2 pages
... Sales force. As previously announced, horizon's commercial effort for rayos will focus on rheumatology indications, including rheumatoid arthritis (ra) and polymyalgia rheumatica (), which ...
November 2012
... As belviq or under a different trade name, we use belviq in this report to refer to the finished drug product for lorcaserin hydrochloride or, depending on the context, lorcaserin hydrochloride or other ...
December 2012
... To establish business venture with significant presence in korean pharmaceutical market - first commercial deal for teva in east asian territory outside japan - - pharmaceutical market in south korea worth ...
January 2013
... Accounted for 15.1% Of the generic drug market (as of 4q12), followed by cj (13.5%), Hanmi (4.7%), Shinpoong (4.0%), And ilong (3.2%). Recommend yuhan as top pick; ckd maintained as second-preferred stock ...
March 2013
... Costs were to increase as multiple clinical trials are conducted simultaneously). 3Dm was planning on starting clinical trials for several pipeline applications, such as its alveolar bone reconstruction ...
January 2013
... For h5n1 vaccines for risk groups Government to engage producer(s) into veterinary vaccine production Niche market for h5n1. Who-hhs meeting on business models, dc, jan 2013 5 ...
» Purchase Premium Reports
(From $ 125 - $ 2 000)
About 200 reports
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Otitis Media, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
February 2013
$ 2 000
Brain Tumor - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Brain Tumor - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...
March 2013
$ 1 088
BMI View: While South Korea's research and development (R&D) environment may be attractive to investors, its pharmaceutical industry environment is rather uncertain given the dispute between pharmaceutical ...
May 2013
$ 652
This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in South Korea. The study provides essential market information for decision-makers ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
March 2013
$ 300
Summary Ildong Pharmaceutical Co., Ltd. (Ildong Pharmaceutical) is a Korea-based pharmaceutical company engaged in the production of pharmaceutical specialties, pharmaceutical raw materials, and environmental ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...